Publication

Population Pharmacokinetics of Dolutegravir in Plasma and Cerebrospinal Fluid in Adults Living With HIV

Explore population PK modeling of dolutegravir in plasma and cerebrospinal fluid to characterize CNS penetration…

CertaraOctober 5, 2026

Publication

Simultaneous Population PKPD Analysis of Belantamab Mafodotin, Soluble BCMA, and Serum M-Protein in Relapsed/Refractory Multiple Myeloma

Explore a simultaneous population PK/PD model characterizing the dynamic relationships between belantamab mafodotin, sBCMA, and…

CertaraOctober 5, 2026

Webinar

How Do You Know You Have the Right Dose? Using Exposure-Response Evidence to Justify and Defend Dose Decisions

Danielle PillsburyOctober 1, 2026

Webinar

Enable AI to Access your PK Data: What’s New in Integral 7.1

CertaraSeptember 24, 2026

White Paper

Model-Informed Strategies for ADC Development

Explore how model informed drug development can help ADC developers optimize dosing, reduce uncertainty, strengthen…

Danielle PillsburySeptember 22, 2026

Publication

Semi-Mechanistic Joint Population Pharmacokinetic Modeling of the Novel Antituberculosis Drug Sorfequiline and Its Metabolite M3 in Healthy Volunteers

A semi-mechanistic population PK model characterizes sorfequiline and its active M3 metabolite to support DDI…

CertaraSeptember 18, 2026

Poster

Pharmacometric Analysis of Givinostat to Support Individualized Dosing Recommendations in Pediatric Patients with Duchenne Muscular Dystrophy

Pharmacometric modeling of givinostat in pediatric DMD supported a simplified 4-band weight-based dosing regimen without…

CertaraSeptember 14, 2026

Guide

From Models to Decisions: Building MIDD Readiness in the Era of ICH M15

Build the governance, capabilities, and cross-functional alignment that turn MIDD evidence into decision-ready evidence under…

Rik de GreefSeptember 9, 2026

On-Demand Webinar

From Sentence to Simulation: Bringing AI Assistance to Pharmacometrics Modeling

Describe pharmacometric models in natural language and let AI write ready-to-run NLME code. See the…

Arjen BosSeptember 1, 2026

Live Events

An Introduction to Fast and Reliable Modeling with RsNLME and Agentic AI

CertaraSeptember 1, 2026

Clinical Pharmacology

Population Pharmacokinetics of Dolutegravir in Plasma and Cerebrospinal Fluid in Adults Living With HIV

Simultaneous Population PKPD Analysis of Belantamab Mafodotin, Soluble BCMA, and Serum M-Protein in Relapsed/Refractory Multiple Myeloma

How Do You Know You Have the Right Dose? Using Exposure-Response Evidence to Justify and Defend Dose Decisions

Enable AI to Access your PK Data: What’s New in Integral 7.1

Model-Informed Strategies for ADC Development

Semi-Mechanistic Joint Population Pharmacokinetic Modeling of the Novel Antituberculosis Drug Sorfequiline and Its Metabolite M3 in Healthy Volunteers

Pharmacometric Analysis of Givinostat to Support Individualized Dosing Recommendations in Pediatric Patients with Duchenne Muscular Dystrophy

From Models to Decisions: Building MIDD Readiness in the Era of ICH M15

From Sentence to Simulation: Bringing AI Assistance to Pharmacometrics Modeling

An Introduction to Fast and Reliable Modeling with RsNLME and Agentic AI

Newsletter sign up

Quick links

Solutions

Contact